Signifor lar and Weight increased - a phase IV clinical study of FDA data

Summary:

Weight increased is reported as a side effect among people who take Signifor lar (pasireotide pamoate), especially for people who are female, 40-49 old, also take Cortef, and have Pituitary-dependent cushing's syndrome.

The phase IV clinical study analyzes which people have Weight increased when taking Signifor lar. It is created by eHealthMe based on reports of 1,198 people who have side effects when taking Signifor lar from the FDA, and is updated regularly.

What is Signifor lar?

Signifor lar has active ingredients of pasireotide pamoate. eHealthMe is studying from 1,198 Signifor lar users. Check the latest studies of Signifor lar.

What is Weight increased?

Weight increased is found to be associated with 2,886 drugs and 3,951 conditions by eHealthMe. Check the latest studies of Weight increased.

On Jul, 14, 2026

1,198 people reported to have side effects when taking Signifor lar.
Among them, 14 people (1.17%) have Weight increased.

Could Signifor lar cause Weight increased?

Among these 14 people:

What is the gender of people who have Weight increased when taking Signifor lar? *

female: 54.55 %
male: 45.45 %

What is the age of people who have Weight increased when taking Signifor lar? *

What are other drugs people take besides Signifor lar? *

Amlodipine: 4 people, 28.57%
Cortef: 4 people, 28.57%
Vitamin D: 3 people, 21.43%
Signifor: 3 people, 21.43%
Janumet: 3 people, 21.43%
Pantoprazole: 3 people, 21.43%
Crestor: 3 people, 21.43%
Calcium: 3 people, 21.43%
Biotin: 1 person, 7.14%
Hydrocortisone Sodium Phosphate: 1 person, 7.14%

What are other side effects people have besides Weight increased? *

Headache (pain in head): 5 people, 35.71%
Hyperglycemia (high blood sugar): 5 people, 35.71%
Diarrhea: 5 people, 35.71%
Injection Site Pain: 4 people, 28.57%
Fatigue (feeling of tiredness): 4 people, 28.57%
Swelling: 4 people, 28.57%
Dyspnea (difficult or laboured breathing): 4 people, 28.57%
Skin Tightness: 4 people, 28.57%
Nausea And Vomiting: 4 people, 28.57%
Dizziness: 3 people, 21.43%

What are the existing conditions these people have? *

Pituitary-Dependent Cushing's Syndrome (pituitary dependent hypercortisolism): 8 people, 57.14%
High Blood Cholesterol: 2 people, 14.29%
Acromegaly (body produces too much growth hormone, leading to excess growth of body tissues): 2 people, 14.29%
Blood Pressure Abnormal: 2 people, 14.29%
Gigantism (excessive growth and height): 2 people, 14.29%
Hyperlipidaemia (presence of excess lipids in the blood): 1 person, 7.14%
High Blood Pressure: 1 person, 7.14%
Hypokalemia (low potassium): 1 person, 7.14%
Headache (pain in head): 1 person, 7.14%
Osteoporosis (bones weak and more likely to break): 1 person, 7.14%

* Approximation only. Some reports may have incomplete information.

Do you take Signifor lar and have Weight increased?

- Check whether Weight increased is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Signifor lar:

Signifor lar (1,198 reports)

Weight increased treatments and more:

Weight increased (279,369 reports)

Browse all side effects of Signifor lar:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Weight increased:

Weight increased (2,886 drugs)

Browse all the conditions that are associated with Weight increased:

Weight increased (3,951 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on pasireotide pamoate (the active ingredients of Signifor lar) and Signifor lar (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.